Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41419-018-0404-5.

Title:
Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer | Cell Death & Disease
Description:
Most of the patients with lung cancer are diagnosed at advanced stage, and they often lose the opportunity of surgical therapy, most of whom fail to reach good prognosis after chemotherapy. Recently, a few clinical studies have confirmed the role of adoptive T-cell transfer in the maintenance therapy of cancer patients. Here, we provided statistical insights into the role of CIKs in advanced lung cancer from three different levels, cell model (in vitro co-culture system), mice model (in situ lung cancer), and clinical research (in lung cancer patients of different progression stages). We optimized the components of supplements and cytokines on activating and expanding CIK cells. Based on this, we explored a new serum-free medium for in vitro activation and expansion of CIK cells. Moreover, we found that activated CIK cells could efficiently kill lung cancer cells in cell-to-cell model in vitro and significantly reduce the tumor growth in mice. For the clinical research, the OS rates of patients received combination of chemotherapy and CIK treatment were significantly improved compared to the OS rates of patients only received chemotherapy. Additionally, CIK therapy represented good toleration in our study. All the results suggested that combination of immunotherapy with traditional therapy will be a feasible and promising method for the treatment of lung cancer.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,554,915 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$536,300 per month
Our analysis indicates Nature.com generates between $357,503 and $983,134 monthly online from display ads.

Keywords {🔍}

cells, cancer, cik, cell, patients, ciks, article, lung, pubmed, fig, google, scholar, therapy, immunotherapy, group, chemotherapy, treatment, activation, day, cas, tumor, cdcd, clinical, study, nature, medium, cytokineinduced, combination, pbmcs, antibody, supplementary, table, killer, mice, days, anticd, flow, pdl, vitro, expansion, activated, nsclc, mabs, cytometry, size, mgm, data, immune, advanced, effect,

Topics {✒️}

nature portfolio privacy policy index cd3+ cd56+ 1 mm × 1 mm × 1 mm tissue pieces advertising nature 505 nature cytokine-induced killer cell sequential cytokine-induced killer t790m-selective egfr-tki combined cytokine-induced killer cells pd-l1-negative cell line reprints tumor-induced immune suppression cytokine-induced killer jianzhong wu & jifeng feng cancer research 1 μg/ml anti-cd3 mabs clinical research overcoming egfr-tki resistance supplementary table 1 supplementary table 2 adoptive t-cell transfer single-cell rna-seq facsverse/calibur/ariaii- sorp annexin v-fitc anti-cd3 monoclonal antibody anti-cd3 monoclonal antibodies improving anti-cancer abilities small-cell lung cancer pd-1 pathway blockade egfr-tki drug resistance mouse anti‑cd3 antibody human anti-cd3 antibody cytokine-induced killers cord blood-derived b7-h1/pd-1 axis pd-1/pd-l1 immunotherapy development fatal adverse reactions original author disease progression occurred permissions mouse anti-cd3 abs cell death dis supplementary fig social media valproate inhibits growth culture media umbilical cord blood

Questions {❓}

  • Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
         description:Most of the patients with lung cancer are diagnosed at advanced stage, and they often lose the opportunity of surgical therapy, most of whom fail to reach good prognosis after chemotherapy. Recently, a few clinical studies have confirmed the role of adoptive T-cell transfer in the maintenance therapy of cancer patients. Here, we provided statistical insights into the role of CIKs in advanced lung cancer from three different levels, cell model (in vitro co-culture system), mice model (in situ lung cancer), and clinical research (in lung cancer patients of different progression stages). We optimized the components of supplements and cytokines on activating and expanding CIK cells. Based on this, we explored a new serum-free medium for in vitro activation and expansion of CIK cells. Moreover, we found that activated CIK cells could efficiently kill lung cancer cells in cell-to-cell model in vitro and significantly reduce the tumor growth in mice. For the clinical research, the OS rates of patients received combination of chemotherapy and CIK treatment were significantly improved compared to the OS rates of patients only received chemotherapy. Additionally, CIK therapy represented good toleration in our study. All the results suggested that combination of immunotherapy with traditional therapy will be a feasible and promising method for the treatment of lung cancer.
         datePublished:2018-03-06T00:00:00Z
         dateModified:2018-03-06T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41419-018-0404-5
         keywords:
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Immunology
            Cell Culture
            Antibodies
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig6_HTML.jpg
         isPartOf:
            name:Cell Death & Disease
            issn:
               2041-4889
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Dan Chen
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huanhuan Sha
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:The Forth Clinical School of Nanjing Medical University
                     address:
                        name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tianmu Hu
               affiliation:
                     name:Purdue University
                     address:
                        name:Department of Biological Science, Purdue University, West Lafayette, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shuchen Dong
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:The Forth Clinical School of Nanjing Medical University
                     address:
                        name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junying Zhang
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Siwen Liu
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Haixia Cao
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rong Ma
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yang Wu
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Changwen Jing
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhuo Wang
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jianzhong Wu
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jifeng Feng
               affiliation:
                     name:Nanjing Medical University Affiliated Cancer Hospital
                     address:
                        name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
      description:Most of the patients with lung cancer are diagnosed at advanced stage, and they often lose the opportunity of surgical therapy, most of whom fail to reach good prognosis after chemotherapy. Recently, a few clinical studies have confirmed the role of adoptive T-cell transfer in the maintenance therapy of cancer patients. Here, we provided statistical insights into the role of CIKs in advanced lung cancer from three different levels, cell model (in vitro co-culture system), mice model (in situ lung cancer), and clinical research (in lung cancer patients of different progression stages). We optimized the components of supplements and cytokines on activating and expanding CIK cells. Based on this, we explored a new serum-free medium for in vitro activation and expansion of CIK cells. Moreover, we found that activated CIK cells could efficiently kill lung cancer cells in cell-to-cell model in vitro and significantly reduce the tumor growth in mice. For the clinical research, the OS rates of patients received combination of chemotherapy and CIK treatment were significantly improved compared to the OS rates of patients only received chemotherapy. Additionally, CIK therapy represented good toleration in our study. All the results suggested that combination of immunotherapy with traditional therapy will be a feasible and promising method for the treatment of lung cancer.
      datePublished:2018-03-06T00:00:00Z
      dateModified:2018-03-06T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41419-018-0404-5
      keywords:
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Immunology
         Cell Culture
         Antibodies
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-018-0404-5/MediaObjects/41419_2018_404_Fig6_HTML.jpg
      isPartOf:
         name:Cell Death & Disease
         issn:
            2041-4889
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Dan Chen
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huanhuan Sha
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:The Forth Clinical School of Nanjing Medical University
                  address:
                     name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tianmu Hu
            affiliation:
                  name:Purdue University
                  address:
                     name:Department of Biological Science, Purdue University, West Lafayette, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shuchen Dong
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:The Forth Clinical School of Nanjing Medical University
                  address:
                     name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junying Zhang
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Siwen Liu
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Haixia Cao
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rong Ma
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yang Wu
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Changwen Jing
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhuo Wang
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jianzhong Wu
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jifeng Feng
            affiliation:
                  name:Nanjing Medical University Affiliated Cancer Hospital
                  address:
                     name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Disease
      issn:
         2041-4889
      volumeNumber:9
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:The Forth Clinical School of Nanjing Medical University
      address:
         name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Purdue University
      address:
         name:Department of Biological Science, Purdue University, West Lafayette, USA
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:The Forth Clinical School of Nanjing Medical University
      address:
         name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Affiliated Cancer Hospital
      address:
         name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Dan Chen
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Huanhuan Sha
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
            name:The Forth Clinical School of Nanjing Medical University
            address:
               name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Tianmu Hu
      affiliation:
            name:Purdue University
            address:
               name:Department of Biological Science, Purdue University, West Lafayette, USA
               type:PostalAddress
            type:Organization
      name:Shuchen Dong
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
            name:The Forth Clinical School of Nanjing Medical University
            address:
               name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Junying Zhang
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Siwen Liu
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Haixia Cao
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Rong Ma
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Yang Wu
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Changwen Jing
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Zhuo Wang
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Jianzhong Wu
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jifeng Feng
      affiliation:
            name:Nanjing Medical University Affiliated Cancer Hospital
            address:
               name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
      name:Department of Biological Science, Purdue University, West Lafayette, USA
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:The Forth Clinical School of Nanjing Medical University, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
      name:Research Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China

Social Networks {👍}(1)

External Links {🔗}(156)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.92s.